Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/28/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Jonathan W. Osgood

Wrong Jonathan W. Osgood?

Co-founder and Managing Member

Cutlass Capital LLC
84 State Street Suite 1040
Boston, Massachusetts 02109
United States

Company Description: Cutlass Capital is a private venture capital partnership investing exclusively in the health care industry. Cutlass Capital was established in August 2001 by Jon...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A. degree
    Amos Truck School of Business at Dartmouth College
  • B.A degree , Economics
    Dartmouth College
39 Total References
Web References
Cutlass Capital
www.cutlasscapital.com, 28 Feb 2014 [cached]
Jonathan W. Osgood 617-867-0820 jonosgood@cutlasscapital.com
Cutlass Capital
www.cutlasscapital.com, 28 Feb 2014 [cached]
Osgood | Jon Osgood Cutlass Capital
...
Jonathan W. Osgood, C.F.A.
Co-Founder and Managing Member, Boston Office.
Prior to founding Cutlass Capital, Jon was a research analyst at Deutsche Banc Alex. Brown and its predecessors from 1983 to 2000. He was Global Head of Health Care Research from 1984 until 2000, and headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide. His industry analytical responsibilities included every sector of health care, with special emphasis on medical technology and health care information systems. Jon was elected several times to the Institutional Investor All-America Research Team and was named a Wall Street Journal All-Star for his stock picking ability.
Jon is a Director of CardioKinetix, Inc., GI Dynamics, Inc., Hemosphere, Inc., TranS1, Inc., and Xoft, Inc. He was previously an Observer on the Board of Evalve, Inc. In addition, he serves on the Board of Overseers of Beth Israel Deaconess Medical Center in Boston.
Jon has a BA (Magna Cum Laude and Phi Beta Kappa) from Dartmouth College and an MBA (Amos Tuck Scholar) from the Amos Tuck School of Business Administration at Dartmouth.
Catalyst Health Ventures - An early stage investor -
www.catalysthealthventures.com, 24 May 2004 [cached]
Jonathan Osgood, Co-founder & Managing Member of Cutlass Capital joined GI Dynamics' Board of Directors. Obesity rates in the U.S. have increased in epidemic proportions over the past 30 years. According to the Centers for Disease Control & Prevention (CDC), today, 31 percent of the U.S. adult population age twenty and over are obese, compared to 14.6 percent in 1971. The U.S. Surgeon General indicates that even moderate weight gain can significantly increase a person's chance of developing heart disease, Type-2 diabetes, sleep apnea, and a whole host of other medical conditions. Importantly, obesity is the second leading cause of preventable death in the U.S. "The GI Dynamics team has shown considerable momentum in its ability to provide valuable solutions to the obesity market," said Jon Osgood, Co-founder & Managing Member, Cutlass Capital. "We look forward to taking an active role in helping the company address the unmet needs of the global obesity market." Jon Osgood brings 25 years of healthcare experience to GI Dynamics' Board of Directors. He was the Global Head of Health Care Research at Deutsche Banc Alex. Brown and its predecessors from 1984 until 2000. At Deutsche Banc Alex. Brown, he headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide. Currently, Jon also holds Director roles with TranS1, Inc., GRAFTcath, Inc., Nutron Medical, Inc., and is on the Board of Overseers at Beth Israel Deaconess Hospital in Boston.
...
"We look forward to working with Jon and his team as we continue our product development and move toward human clinical studies."
GI Dynamics Raises $12 Million in Series B Financing to Address Unmet Needs in Obesity Market
www.prnewswire.com, 24 May 2004 [cached]
Jonathan Osgood, Co-founder & Managing Member of Cutlass Capital joined GI Dynamics' Board of Directors.
Obesity rates in the U.S. have increased in epidemic proportions over the past 30 years.According to the Centers for Disease Control & Prevention (CDC), today, 31 percent of the U.S. adult population age twenty and over are obese, compared to 14.6 percent in 1971.The U.S. Surgeon General indicates that even moderate weight gain can significantly increase a person's chance of developing heart disease, Type-2 diabetes, sleep apnea, and a whole host of other medical conditions.Importantly, obesity is the second leading cause of preventable death in the U.S.
"The GI Dynamics team has shown considerable momentum in its ability to provide valuable solutions to the obesity market," said Jon Osgood, Co-founder & Managing Member, Cutlass Capital."We look forward to taking an active role in helping the company address the unmet needs of the global obesity market."
Jon Osgood brings 25 years of healthcare experience to GI Dynamics' Board of Directors.He was the Global Head of Health Care Research at Deutsche Banc Alex.Brown and its predecessors from 1984 until 2000.At Deutsche Banc Alex.Brown, he headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide.Currently, Jon also holds Director roles with TranS1, Inc., GRAFTcath, Inc., Nutron Medical, Inc., and is on the Board of Overseers at Beth Israel Deaconess Hospital in Boston.
...
"We look forward to working with Jon and his team as we continue our product development and move toward human clinical studies."
Board of Directors | Trans1
trans1.com, 17 Feb 2013 [cached]
Jon Osgood Jonathan Osgood has served as a member of our Board since March 2002. In 2001, Mr. Osgood co-founded, and is a managing member of, Cutlass Capital, L.L.C a venture capital firm that invests exclusively in the healthcare industry. Mr. Osgood has served as a member of the board of directors of several privately-held medical device companies and as a member of the audit committee and compensation committee of several of such companies. Mr. Osgood is a Certified Financial Analyst and received a B.A degree in Economics from Dartmouth College and an M.B.A. degree from the Amos Truck School of Business at Dartmouth College.
Mr. Osgood's experience and attributes qualify him to serve on our Board for several reasons. Virtually his entire 38 year business career has been spent in and around the health care industry. From 1984 until 2000, Mr. Osgood led Alex. Brown & sons' and Deutsche Bank's Health Care Research practice, where he advised clients in their health care investing strategy. From 2001 to the present, as a managing member of Cutlass Capital, L.L.C., Mr. Osgood has been investing in privately owned health care companies, primarily in the medical device space. As a result of this experience, Mr. Osgood has broad and deep experience in working with and analyzing health care companies, and has developed a large network of health care company executives, entrepreneurs, physicians, investment bankers and venture capitalists.
Other People with the name "Osgood":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304